96 related articles for article (PubMed ID: 8764369)
1. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation.
Thomas WL; Cooke ES; Hammer RP
J Pharmacol Exp Ther; 1996 Jul; 278(1):347-53. PubMed ID: 8764369
[TBL] [Abstract][Full Text] [Related]
2. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
Pierce RC; Born B; Adams M; Kalivas PW
J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
[TBL] [Abstract][Full Text] [Related]
3. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
4. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration.
Unterwald EM; Ho A; Rubenfeld JM; Kreek MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):1387-96. PubMed ID: 7932193
[TBL] [Abstract][Full Text] [Related]
5. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
[TBL] [Abstract][Full Text] [Related]
6. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
Steketee JD
Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
[TBL] [Abstract][Full Text] [Related]
7. Alterations in locomotor activity during chronic cocaine administration: effect on dopamine receptors and interaction with opioids.
Kunko PM; French D; Izenwasser S
J Pharmacol Exp Ther; 1998 Apr; 285(1):277-84. PubMed ID: 9536022
[TBL] [Abstract][Full Text] [Related]
8. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
Trugman JM; Arnold WS; Touchet N; Wooten GF
J Pharmacol Exp Ther; 1989 Sep; 250(3):1156-60. PubMed ID: 2674418
[TBL] [Abstract][Full Text] [Related]
9. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
Ruskin DN; Bergstrom DA; Walters JR
J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
[TBL] [Abstract][Full Text] [Related]
10. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Chausmer AL; Katz JL
Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat.
Schmidt HD; Anderson SM; Pierce RC
Eur J Neurosci; 2006 Jan; 23(1):219-28. PubMed ID: 16420431
[TBL] [Abstract][Full Text] [Related]
12. Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist.
Morelli M; Pontieri FE; Linfante I; Orzi F; Di Chiara G
Synapse; 1993 Mar; 13(3):264-9. PubMed ID: 8098880
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with a dopamine D1-receptor antagonist prevents metabolic activation by cocaine.
Thomas WL; Cooke ES; Hammer RP
Neurosci Lett; 1995 Aug; 196(3):161-4. PubMed ID: 7501273
[TBL] [Abstract][Full Text] [Related]
14. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
Martin LP; Waszczak BL
Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
[TBL] [Abstract][Full Text] [Related]
17. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
18. Strain differences in the effects of adrenalectomy on the midbrain dopamine system: implication for behavioral sensitization to cocaine.
de Jong IE; Steenbergen PJ; de Kloet ER
Neuroscience; 2008 May; 153(3):594-604. PubMed ID: 18420350
[TBL] [Abstract][Full Text] [Related]
19. Gradual tolerance of metabolic activity is produced in mesolimbic regions by chronic cocaine treatment, while subsequent cocaine challenge activates extrapyramidal regions of rat brain.
Hammer RP; Cooke ES
J Neurosci; 1994 Jul; 14(7):4289-98. PubMed ID: 8027779
[TBL] [Abstract][Full Text] [Related]
20. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]